Author:
Kim Hong-Bae,Kim Jung-Ha,Wolf Bethany J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference13 articles.
1. Higgins JPT, Green S (editors) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.handbook.cochrane.org. Accessed 14 October 2021
2. Blanc F, Waechter C, Vogel T et al (2020) Preprint. https://doi.org/10.20944/preprints202005.0016.v1
3. McKeigue PM, Kennedy S, Weir A et al (2020) Associations of severe COVID-19 with polypharmacy in the REACT-SCOT case-control study. medRxiv. https://doi.org/10.1101/2020.07.23.20160747
4. Li J, Cao J, Cai P et al (2020) Risk factors of secondary infections in severe and critical patients hospitalized with COVID-19: a case-control study. Preprint. Research Square. https://doi.org/10.21203/rs.3.rs-55958/v1
5. Ullah AZMD, Sivapalan L, Kocher HM, Chelala C (2020) COVID-19 in patients with hepatobiliary and pancreatic diseases in East London: a single-centre cohort study. medRxiv. https://doi.org/10.1101/2020.09.07.20189621